Peter McCaffrey

The University of Texas Medical Branch at Galveston

Papers

Total Citations

H-Index

About

Peter McCaffrey is a translational virologist whose research centers on the development and deployment of live-virus neutralization assays to combat emerging viral threats. His major contribution lies in bridging the gap between high-containment research and routine clinical diagnostics. McCaffrey led the creation of an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay, a breakthrough that allows for the safe, rapid, and scalable monitoring of neutralizing antibodies against SARS-CoV-2 and its variants of concern. By engineering a highly attenuated virus (Δ3678_WA1-s), his team eliminated the need for BSL-3 facilities, making critical serological surveillance accessible to a wider range of clinical and public health laboratories. This work, published in 2023, has already garnered 5 citations and is foundational for tracking vaccine efficacy and immune escape. McCaffrey’s achievements include establishing a direct pipeline from bench research to patient care, ensuring that real-time immune monitoring can keep pace with viral evolution. His platform stands as a model for agile, safe, and clinically relevant virology in the post-pandemic era.